MCA
NVAX icon

Maryland Capital Advisors’s Novavax NVAX Stock Holding History

Maryland Capital Advisors’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.63K Buy
+173
New +$1.55K ﹤0.01% 242
2025
Q4 		$1.16K Hold
173
– – ﹤0.01% 254
2025
Q3 		$1.5K Hold
173
– – ﹤0.01% 230
2025
Q2 		$1.09K Buy
+173
New +$1.15K ﹤0.01% 246

Other funds holding NVAX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
TCMG
TSP Capital Management Group Summit, New Jersey $418M AUM 68.45% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $1.26B AUM 60.23% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
OC
Oppenheimer & Co New York $9.37B AUM 36.4% 1-Year Est. Return

Maryland Capital Advisors's NVAX Position: Q2 2026 in Review

Maryland Capital Advisors opened a new position in Novavax (NVAX) in Q2 2026: 173 shares worth $1.63K. The stake represents ﹤0.01% of the portfolio and ranks #242 among its holdings. This is a return to the name: Maryland Capital Advisors previously reported a position in NVAX as recently as Q4 2025.

Maryland Capital Advisors first reported a position in NVAX in Q2 2025 and has held it in 4 quarters since. 104 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • Maryland Capital Advisors held 173 shares of Novavax worth $1.63K as of Q2 2026.
  • Novavax was a new Maryland Capital Advisors position in Q2 2026.
  • Novavax made up ﹤0.01% of Maryland Capital Advisors's portfolio in Q2 2026, its #242 holding.
  • Maryland Capital Advisors first reported a position in Novavax in Q2 2025 and has held it in 4 quarters since.
  • 104 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on Maryland Capital Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.